242 related articles for article (PubMed ID: 19097655)
1. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
[TBL] [Abstract][Full Text] [Related]
2. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
4. Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy.
Matsubara H; Nakatani S; Nagata S; Ishikura F; Katagiri Y; Ohe T; Miyatake K
J Am Coll Cardiol; 1995 Sep; 26(3):768-75. PubMed ID: 7642872
[TBL] [Abstract][Full Text] [Related]
5. Pacing in obstructive hypertrophic cardiomyopathy: a therapeutic option?
Kukar A; Sherrid MV; Ehlert FA
Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():49-54. PubMed ID: 17162271
[TBL] [Abstract][Full Text] [Related]
6. [Long-term beneficial effect of dual chamber pacing in a patient with hypertrophic obstructive cardiomyopathy].
Takahashi M; Horinaka S; Takada M; Matsumoto N; Tsuchiya N; Yabe A; Onoda M; Murate J; Masuda T; Ishikawa K; Takeda K; Matsuoka H
J Cardiol; 1997 Jun; 29(6):345-52. PubMed ID: 9211094
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy.
Sherrid MV; Barac I; McKenna WJ; Elliott PM; Dickie S; Chojnowska L; Casey S; Maron BJ
J Am Coll Cardiol; 2005 Apr; 45(8):1251-8. PubMed ID: 15837258
[TBL] [Abstract][Full Text] [Related]
8. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy.
Gadler F; Linde C; Juhlin-Dannfeldt A; Ribeiro A; Rydén L
J Am Coll Cardiol; 1996 Apr; 27(5):1219-24. PubMed ID: 8609346
[TBL] [Abstract][Full Text] [Related]
9. Effect of biventricular pacing on left ventricular outflow tract pressure gradient in a patient with hypertrophic cardiomyopathy and normal interventricular conduction.
Komsuoglu B; Vural A; Agacdiken A; Ural D
J Cardiovasc Electrophysiol; 2006 Feb; 17(2):207-9. PubMed ID: 16533259
[TBL] [Abstract][Full Text] [Related]
10. Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy.
Lucon A; Palud L; Pavin D; Donal E; Behar N; Leclercq C; Mabo P; Daubert JC
Arch Cardiovasc Dis; 2013; 106(6-7):373-81. PubMed ID: 23806305
[TBL] [Abstract][Full Text] [Related]
11. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
Terrosu P; Franceschino V; Contini GM; Dore L; Ibba GV
G Ital Cardiol; 1984 Jan; 14(1):63-6. PubMed ID: 6538527
[TBL] [Abstract][Full Text] [Related]
12. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy.
Fananapazir L; Cannon RO; Tripodi D; Panza JA
Circulation; 1992 Jun; 85(6):2149-61. PubMed ID: 1350522
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of dual-chamber pacing with periodic echocardiographic evaluation of optimal atrioventricular delay in patients with hypertrophic cardiomyopathy >50 years of age.
Topilski I; Sherez J; Keren G; Copperman I
Am J Cardiol; 2006 Jun; 97(12):1769-75. PubMed ID: 16765132
[TBL] [Abstract][Full Text] [Related]
14. The importance of ventricular septal morphology in the effectiveness of dual chamber pacing in hypertrophic obstructive cardiomyopathy.
Dimitrow PP; Grodecki J; Bacior B; Dudek D; Legutko J; Jaszcz KK; Dubiel JS
Pacing Clin Electrophysiol; 2000 Sep; 23(9):1324-9. PubMed ID: 11025886
[TBL] [Abstract][Full Text] [Related]
15. Disopyramide for Hypertrophic Cardiomyopathy: A Pragmatic Reappraisal of an Old Drug.
Verlinden NJ; Coons JC
Pharmacotherapy; 2015 Dec; 35(12):1164-72. PubMed ID: 26684556
[TBL] [Abstract][Full Text] [Related]
16. Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial.
Nishimura RA; Trusty JM; Hayes DL; Ilstrup DM; Larson DR; Hayes SN; Allison TG; Tajik AJ
J Am Coll Cardiol; 1997 Feb; 29(2):435-41. PubMed ID: 9015001
[TBL] [Abstract][Full Text] [Related]
17. [The treatment of hypertrophic obstructive cardiomyopathy refractory to medical treatment by DDD pacing].
Tascón J; Albarrán A; Pérez-Carasa MA; Andreu J; Rodríguez J; Coma R; Cosío FG
Rev Esp Cardiol; 1994 May; 47(5):294-302. PubMed ID: 8016438
[TBL] [Abstract][Full Text] [Related]
18. [Anesthetic management of a patient with mid-ventricular obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing].
Hoshikawa T; Otaki K; Suzuki C; Takahashi T; Higuchi T; Kawamae K
Masui; 2008 Feb; 57(2):216-8. PubMed ID: 18277576
[TBL] [Abstract][Full Text] [Related]
19. [Value of permanent cardiac pacing in hypertrophic and obstructive cardiomyopathies resistant to medical treatment].
Sadoul N; Simon JP; de Chillou C; Bruntz JF; Isaaz K; Beurrier D; Reeb T; Dodinot B; Aliot E
Arch Mal Coeur Vaiss; 1994 Oct; 87(10):1315-23. PubMed ID: 7771876
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing.
Megevand A; Ingles J; Richmond DR; Semsarian C
Am J Cardiol; 2005 Apr; 95(8):991-3. PubMed ID: 15820173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
